A successful switch from guselkumab to tildrakizumab during the treatment of a patient with psoriasis vulgaris

被引：0
|
作者：
Yatsuzuka, Kazuki [1 ]
Murakami, Masamoto [1 ]
机构：
[1] Ehime Univ, Dept Dermatol, Grad Sch Med, Toon, Ehime 7910295, Japan
来源：
JOURNAL OF CUTANEOUS IMMUNOLOGY AND ALLERGY | 2023年 / 6卷 / 03期
关键词：
D O I：
10.1002/cia2.12284
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：98 / 99
页数：2
相关论文
共 50 条
  • [11] Dermatitis during efalizumab treatment in a patient with psoriasis vulgaris
    de Groot, M
    de Rie, MA
    Bos, JD
    BRITISH JOURNAL OF DERMATOLOGY, 2005, 153 (04) : 843 - 845
  • [12] Successful ustekinumab treatment of severe refractory psoriasis vulgaris in a hemodialysis patient
    Michelerio, Andrea
    Ciolfi, Christian
    Rotatore, Giuseppe
    Grosjean, Fabrizio
    Brazzelli, Valeria
    ITALIAN JOURNAL OF DERMATOLOGY AND VENEREOLOGY, 2021, 156 (04) : 510 - 511
  • [13] Drug survival and clinical effectiveness of secukinumab, ixekizumab, brodalumab, guselkumab, risankizumab, tildrakizumab for psoriasis treatment
    Mastorino, Luca
    Dapavo, Paolo
    Susca, Sara
    Cariti, Caterina
    Siliquini, Niccolo
    Verrone, Anna
    Stroppiana, Elena
    Ortoncelli, Michela
    Quaglino, Pietro
    Ribero, Simone
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2024, 22 (01): : 44 - 44
  • [14] Plantar pustules in a psoriasis patient during the guselkumab therapy
    Nakazawa, Shinsuke
    Honda, Tetsuya
    JOURNAL OF CUTANEOUS IMMUNOLOGY AND ALLERGY, 2021, 4 (05) : 143 - 144
  • [15] A Case Report of Successful Treatment of Crohn's Disease and Psoriasis With Guselkumab
    Grossberg, Laurie B.
    INFLAMMATORY BOWEL DISEASES, 2019, 25 (07) : E84 - E84
  • [16] Guselkumab, tildrakizumab, and risankizumab in a real-world setting: drug survival and effectiveness in the treatment of psoriasis and psoriatic arthritis
    Elgaard, Cathrine Dawn Buttner
    Iversen, Lars
    Hjuler, Kasper Fjellhaugen
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2023, 34 (01)
  • [17] Limited Changes in Hematological Parameters During Tildrakizumab Treatment: Post Hoc Analysis of Data from the Tildrakizumab Psoriasis Clinical Program
    Glover, Holly
    Kucera, Kristine
    Mendelsohn, Alan
    Parno, Jeff
    Rozzo, Stephen
    Ferritto, Frank
    Block, Renata
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [18] Limited changes in hematological parameters during tildrakizumab treatment: Post hoc analysis of data from the Tildrakizumab Psoriasis Clinical Program
    Glover, Holly
    Kucera, Kristine
    Mendelsohn, Alan M.
    Parno, Jeff
    Rozzo, Stephen J.
    Ferritto, Frank
    Block, Renata
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB87 - AB87
  • [19] Successful treatment of hydrarthrosis of the knee with guselkumab in a patient with palmoplantar pustulosis
    Ikumi, Natsumi
    Fujita, Hideki
    JOURNAL OF DERMATOLOGY, 2024, 51 (12): : e438 - e439
  • [20] Vitamin A Treatment for Psoriasis Vulgaris in a Dialysis Patient
    Inoue, Tsuyoshi
    Nangaku, Masaomi
    Yamada, Koei
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2013, 62 (05) : 1020 - 1021
12345